Disclosure 0001873394-26-000005-1

SEC FORM 4

$14,852.17

Entrada Therapeutics, Inc. (TRDA)

Disposition (code F) of 2,079 shares at $7.1439 per share.

Reporting Person Sethuraman Natarajan · Officer Title President, Research & Develop. · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001873394-26-000005 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Entrada Therapeutics, Inc. (TRDA)." Disclosed 2026-09-03. https://desqlong.com/cards/0001873394-26-000005-1 (retrieved 2026-09-26).